Enterprise Ireland grant awarded to ICON to further enhance artificial intelligence capabilities. Dublin, Ireland – 30 January 2025 – ICON plc, (NASDAQ: ICLR) a world-leading clinical …

2025年1月27日 · Pharmaceutical articles from around the world. The Active Pharmaceutical Ingredient (API) Market is projected to reach a multimillion-dollar valuation by 2034, driven by …

5 天之前 · If approved, depemokimab will be the first ultra-long-acting biologic with 6-month dosing Submissions based on data from positive SWIFT and ANCHOR trials SWIFT-1 and -2 …

3 天之前 · Date Title Company; 31-Jan-2025: Refractive Surgery Device Market Poised for Steady Growth, Expected to Reach USD 312.3 Million by 2034 at a 3.90% CAGR

2025年1月8日 · If you’ve worked in the life sciences industry over the past few years, or have been trying to break into it, then you’ll already know that the 2023 and 2024 job markets …

2025年1月14日 · Artificial intelligence has transformed many industries and processes, and some decision-makers are exploring how to apply AI to meet specific needs. They are also …

6 天之前 · The medical robotics industry has undergone significant transformations in recent years, driven by technological advancements, increasing demand for precision in medical …

2025年1月14日 · Biologic approvals, drug delivery advancements, GLP-1 generics and the long-sought funding return to drive a record year in 2025. Paris, 13 th January, 2025: Pharmapack …

2025年1月7日 · Report signals industry-wide growth headlined by obesity and oncology therapy areas. LONDON – [7 th January 2025] – Evaluate, the leading provider of market insights for …

2024年11月19日 · Catumaxomab received a positive opinion from the EMA's Committee for Medicinal Products for Human Use (CHMP) at its October 2024 meeting and if approved …